Skip header and navigation

2 records – page 1 of 1.

Document Type
Rapid Review
Review Code
EOC081401v2 RR
Question Submitted
August 14, 2020
Date Completed
December 1, 2020
Status
5. Updated review
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC081401v2 RR
Question Submitted
August 14, 2020
Date Completed
December 1, 2020
Status
5. Updated review
Research Team
EOC
Key Findings
In the absence of SARS-CoV-2 specific evidence, recommendations for fallow time following AGPs in the context of the SARS-CoV-2 pandemic range widely depending on country and specialty association.
The majority of recommendations are based upon dental practices and several on thoracic surgical practice.
The most common recommendations follow the CDC’s guidelines for airborne contamination removal based on air changes per hour ventilation properties of rooms.
Assuming that most treatment rooms have a minimum of 10-12 ACH, most associations recommend a 20-minute fallow periods, or 60 minutes if ACH is unknown or below recommendations for treatment rooms.
Category
Administration
Infection Prevention and Control
Subject
Aerosols
Facilities
Decision Making
Priority Level
Level 4 completed within 1 week
Cite As
Badea, A; Groot G; Dalidowicz, M; Young, C; Miller, L. What are the recommendations around settling times following aerosol generating procedures on suspected or confirmed COVID-19 patients? 2020 Dec 1; Document no.: EOC081401v2 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 24 p. (CEST rapid review report)
Review History
EOC081401 RR: August 24, 2020
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
LAB041601v2 RR
Question Submitted
April 16, 2020
Date Completed
May 19, 2020
Status
5. Updated review
Research Team
Laboratory
Document Type
Rapid Review
Review Code
LAB041601v2 RR
Question Submitted
April 16, 2020
Date Completed
May 19, 2020
Status
5. Updated review
Research Team
Laboratory
Key Findings
Patients with higher and prolonged IgM antibodies are associated with more severe illness, poor recovery, and prolonged viral shedding (some patients may shed virus for more than 30 days).
Patients who respond weakly to IgG have higher viral clearance rate than strong responders.
There were no reports with direct information regarding infectiousness of patients.
Category
Diagnostics
Clinical Presentation
Subject
Transmission
Antibodies
Natural History
Population
All
Cite As
Vanstone, J; Reeder, B; Duncan, V. What is the relationship between antibody development and viral shedding and infectiousness? 2020 May 19; Document no.: LAB041601v2 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 5 p. (CEST rapid review report)
Review History
LAB041601 RR: April 16, 2020
Related Documents
Documents
Less detail